Clin2
NCT05541250Possibly a fitRecruiting

Stem-like nerve cell treatment for severe nerve injuries

Peripheral Nerve Injury

Part of Brain & nervous system, Injuries & trauma clinical trials.

This Phase 1 study tests whether adding a patient’s own nerve support cells to a severely injured nerve is safe and helpful. It’s for people with recent major nerve damage in an arm or leg, with strict safety checks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You have a severe nerve injury in a major arm or leg nerve (sciatic, brachial plexus, or another major nerve) within the last year
  • You are 18 to 65 years old
  • You can safely have an MRI scan
  • The gap in the injured nerve is not longer than 10 cm
  • You can have a small nerve sample taken from the leg area used for this treatment, and nothing stops that process

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07657182Recruiting· Phase 4
Study comparing two nerve grafts for arm or hand recovery

This study tests a new nerve graft (Avance) against the standard sural nerve graft (taken from your leg) for repairing cut nerves in the arm or hand. The goal is to see which helps you recover function better over 2 years.

Indianapolis, Indiana
NCT02795052Recruiting
Stem cell treatment trial for nerve injury

This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.

Westport, Connecticut
NCT04812431Recruiting· Phase 1/Phase 2
Tested stem cell transplant therapy for severe spinal cord injury

This trial tests a cell transplant approach for people with a very severe spinal cord injury. It focuses first on safety and also looks for early signs the therapy may improve function.

Suwon, Gyeonggido
NCT06976229Recruiting· Phase 1
Stem cell therapy for recent spinal cord injury

This phase 1 trial tests a new treatment made from stem cells (XS228) for people who had a spinal cord injury 14 to 60 days ago. Doctors want to see if it's safe and if it might help with recovery.

Guangzhou, Guangdong
NCT05018793Recruiting· Phase 1
Testing stem cell injections for spinal cord injury safety

This early study tests whether two types of stem cells—made from your own fat cells versus from donated umbilical-cord cells—are safe when injected into the fluid around the spinal cord. It may help researchers find safer cell-based options for people with spinal cord injury.

St John's
NCT06981338Not yet recruiting· Phase 1/Phase 2
Stem cells and spinal stimulation for chronic spinal cord injury

This trial tests a combination of stem cells injected into the spinal fluid and a non-invasive spinal cord stimulation device to see if they can improve recovery after a spinal cord injury. It is for people who have had a single traumatic injury between neck and mid-back, 1 to 5 years ago, and are in stable health.

Badalona, Barcelona, Catalonia

Hear when a new Peripheral Nerve Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.